Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
TuHURA Biosciences, Inc. (HURA) had Stock-Based Compensation of $1.42M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.67M |
|
-- |
|
-- |
|
$7.02M |
|
$-7.02M |
|
$0.35M |
|
$-6.66M |
|
$-6.66M |
|
$-6.66M |
|
$-6.66M |
|
$-6.66M |
|
$-6.66M |
|
$-7.02M |
|
$-7.00M |
|
43.41M |
|
43.41M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$14.33M |
|
$0.15M |
|
$0.31M |
|
$14.64M |
|
$4.78M |
|
-- |
|
-- |
|
$4.78M |
|
$9.58M |
|
$9.86M |
|
$9.86M |
|
43.68M |
|
| Cash Flow Statement Financials | |
$-4.74M |
|
$-1.15M |
|
$-0.55M |
|
$12.66M |
|
$6.22M |
|
$-6.44M |
|
|
Stock-Based Compensation |
$1.42M |
-- |
|
$-0.00M |
|
| Fundamental Metrics & Ratios | |
3.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-69.58% |
|
-67.61% |
|
-45.53% |
|
-67.61% |
|
$0.23 |
|
$-0.11 |
|
$-0.11 |
|